AP NEW YORKRegeneron Pharmaceuticals Inc. says regulators approved marketing of its eye drug Eylea, an injection designed to treat a common cause of blindness in senior citizens. Eylea is intended to treat "wet" age-related macular degeneration. ... FDA approves Regeneron's eye injection Eylea
Thursday, November 17, 2011
FDA approves Regeneron's eye injection Eylea
AP NEW YORKRegeneron Pharmaceuticals Inc. says regulators approved marketing of its eye drug Eylea, an injection designed to treat a common cause of blindness in senior citizens. Eylea is intended to treat "wet" age-related macular degeneration. ... FDA approves Regeneron's eye injection Eylea
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment